Regen Therapeutics has been selected by Georgia medical professionals as the preferred regenerative hair restoration practice in the state, recognizing its commitment to safety, innovation, and medically supervised post-chemotherapy hair recovery. The Sandy Springs-based practice specializes in regenerative hair restoration using advanced biologic therapies and all-natural, non-prescription support protocols, working exclusively with patients who have completed chemotherapy and received medical clearance from their oncology teams.
The recognition underscores the clinic's patient-first philosophy and rigorous adherence to regulatory standards. Dr. Keith D. Kantor, PhD, Clinic Director of Regen Therapeutics, stated that the acknowledgment affirms the practice's unwavering commitment to safety, regulatory compliance, and collaboration with physicians to ensure optimal patient outcomes. The clinic's mission focuses on restoring not just hair but confidence and quality of life for individuals recovering from cancer treatment.
Regen Therapeutics utilizes umbilical cord-derived regenerative biologics obtained from full-term, healthy cesarean-section deliveries with maternal consent and hospital verification. All biologic material is processed in FDA-regulated, cGMP-compliant laboratories and screened under FDA infectious-disease standards before being administered via localized scalp injections to support follicle regeneration. The clinic's protocols are strictly non-drug-based, incorporating nutrient-based topical therapies, natural topical DHT blockers, and scalp stimulation treatments, all introduced only after oncology approval and chemotherapy completion.
Dr. Kantor emphasized that no patient begins treatment without explicit oncology clearance, highlighting the essential collaboration with medical professionals to prioritize patient safety. The practice operates within rigorous regulatory standards at every stage of care, maintaining strict patient acceptance criteria and only seeing post-chemotherapy patients with documented approval from their treating oncologist. The program is specifically designed for patients experiencing post-chemotherapy hair thinning and scalp health challenges, with structured communication and documentation provided to oncology partners to ensure coordinated care.
To further support oncology patients, Regen Therapeutics offers a 25% referral discount, priority appointment scheduling, and post-treatment support guidance. Dr. Kantor noted that the clinic's role begins only after cancer treatment has concluded, working with oncologists to support patients during the emotional recovery phase and help them regain a sense of normalcy as their hair returns. The practice does not rely on prescription hair-loss drugs, instead focusing on regenerative biologics and natural therapies within regulatory guidelines.
The recognition by Georgia's medical community highlights Regen Therapeutics' leadership in regenerative hair restoration and its dedication to a collaborative, safety-focused approach. This development matters as it represents a growing emphasis on integrative post-cancer care, potentially setting standards for how regenerative therapies are administered in medically supervised contexts. For patients recovering from chemotherapy, it offers a specialized, non-pharmaceutical option for hair restoration that prioritizes safety through direct oncology collaboration, addressing both physical and emotional aspects of recovery. The industry may see increased attention to regulatory compliance and interdisciplinary partnerships in regenerative medicine, while the broader healthcare landscape could benefit from models that bridge oncology and restorative care to improve patient quality of life after treatment.
